Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -4.693% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CN(C(=O)c1ccccc1NC(=O)C(F)(F)F)c1ccccc1
b.) COc1ccc(OC)c(Cc2nnc(CCC(=O)N3CCN(C4CCCC4)CC3)o2)c1
Answer: b. COc1ccc(OC)c(Cc2nnc(CCC(=O)N3CCN(C4CCCC4)CC3)o2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(OC)c(Cc2nnc(CCC(=O)N3CCN(C4CCCC4)CC3)o2)c1
COc1ccc(OC)c(Cc2nnc(CCC(=O)N3CCN(C4CCCC4)CC3)o2)c1
1-(4-cyclopentylpiperazin-1-yl)-3-[5-[(2,5-dimethoxyphenyl)methyl]-1,3,4-oxadiazol-2-yl]propan-1-one